Dr Rhys Ponton

BPharm, PhD, Pharmacist Independent Prescriber (UK).

Teaching | Current

Course Director:

  • Pharmacy 411 (Undergraduate, final year course with Oncology, Neurology and Psychiatry (inc. drug misuse) modules)
  • Pharmacy 767 (Postgraduate course, Postgraduate diploma)
  • Pharmacy 769 & Pharmacy 770 (Postgraduate Pharmacist Prescribing)

 

Module Leader:

  • Pharmacy 411 Psychiatry and Drug Misuse  

 

Lectures and Workshop Teaching:

  • P213, P311, P411, P769/770

 

University of Auckland:

  • MBChB 501A School of Medical Sciences/School of Population Health 
  • 111G General Education 'Drugs and Society’ 

 

International:

  • Diploma in Clinical Pharmacy – PHM036 - Online Distance: Developing and Implementing Models of Care, The Robert Gordon University, Aberdeen, UK. 

 

Responsibilities

Course Director:

  • Pharmacy 411 (Undergraduate, final year course with Oncology, Neurology and Psychiatry (inc. drug misuse) modules)
  • Pharmacy 767 (Postgraduate course, Postgraduate diploma)
  • Pharmacy 769 & Pharmacy 770 (Postgraduate Pharmacist Prescribing)

Areas of expertise

  • Drug policy, in particular the impact this has on the health of drug users
  • Drug misuse, specifically methods used by drug users to ingest drugs, the risks posed by these routes and the development of measures to reduce harm during illicit drug use
  • Treatment of substance use disorders
  • Pain treatment and the use of opioid analgesics in chronic pain 
  • Medicines optimisation in primary care
  • Mental health

Committees/Professional groups/Services

2017 onwards – Governance Board member, Healthcare Career Pathways Project (formerly the Faculty Tracking Project), FMHS

2017 onwards – Scientific Committee member, Healthcare Career Pathyways Project (formerly Faculty Tracking Project), FMHS

Selected publications and creative works (Research Outputs)

  • McMillan, R., Sumner, R., Forsyth, A., Campbell, D., Malpas, G., Maxwell, E., ... Sundram, F. (2020). Simultaneous EEG/fMRI recorded during ketamine infusion in patients with major depressive disorder. Progress in neuro-psychopharmacology & biological psychiatry, 9910.1016/j.pnpbp.2019.109838
    Other University of Auckland co-authors: Rachael Sumner, Frederick Sundram, Suresh Muthukumaraswamy, Anna Forsyth, Rebecca McMillan
  • Ponton, R., & George, J. (2020). Pharmaceutical opioid changes risk overdose increase in New Zealand. The New Zealand medical journal, 133 (1511), 95-96.
  • Sumner, R. L., McMillan, R., Spriggs, M. J., Campbell, D., Malpas, G., Maxwell, E., ... Kirk, I. J. (2020). Ketamine Enhances Visual Sensory Evoked Potential Long-term Potentiation in Patients With Major Depressive Disorder. Biological psychiatry. Cognitive neuroscience and neuroimaging, 5 (1), 45-55. 10.1016/j.bpsc.2019.07.002
    URL: http://hdl.handle.net/2292/48823
    Other University of Auckland co-authors: Rebecca McMillan, Rachael Sumner, Suresh Muthukumaraswamy, Ian Kirk, Frederick Sundram
  • Ponton, R., Noller, G., Berry, R., & Bullen, C. (2019). ILLICIT DRUG INJECTION IN NEW ZEALAND: DETAILING THE PROCESS TO REDUCE THE HARMS. DRUG AND ALCOHOL REVIEW. (pp. 1).
    Other University of Auckland co-authors: Chris Bullen
  • Ponton, R. (2019). Faking it: the use of imitation drugs in research interviews. JOURNAL OF SUBSTANCE USE10.1080/14659891.2019.1659870
  • Sheridan, J. L., Nielsen, S., & Ponton, R. (2019). Drug misuse and dependence: The role of community pharmacy. Encyclopedia of Pharmacy Practice and Clinical Pharmacy (pp. 268-277). 10.1016/B978-0-128-12735-3.00064-9
    Other University of Auckland co-authors: Janie Sheridan
  • Ponton, R., & Yan, S. (5/11/2018). Predicting harms posed by the illicit injection of pharmaceutical preparations in New Zealand. Poster presented at Australasian Professional Society on Alcohol & other Drugs (APSAD) 2018, Auckland, New Zealand. Drug and Alcohol Review (Nov 2018), 37 (Suppl. 3), 1–75. Related URL.
    URL: http://hdl.handle.net/2292/45277
  • Ponton, R., Sheridan, J., & Nielsen, S. (2018). NALOXONE PROVISION BY COMMUNITY PHARMACISTS IN NEW ZEALAND: EXPLORATION OF PHARMACISTS UNDERSTANDING OF NALOXONE, THEIR OPINIONS ON THIS NEW SERVICE PROPOSAL AND THEIR EXPERIENCE OF OVERDOSE IN CLOSE ACQUAINTANCES. DRUG AND ALCOHOL REVIEW. (pp. 1).
    Other University of Auckland co-authors: Janie Sheridan

Identifiers

Contact details

Primary office location

M&HS BUILDING 505 - Bldg 505
Level 3, Room 364
85 PARK RD
GRAFTON
AUCKLAND 1023
New Zealand

Web links